BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22669545)

  • 1. A reformulated spherule-derived coccidioidin (Spherusol) to detect delayed-type hypersensitivity in coccidioidomycosis.
    Johnson R; Kernerman SM; Sawtelle BG; Rastogi SC; Nielsen HS; Ampel NM
    Mycopathologia; 2012 Dec; 174(5-6):353-8. PubMed ID: 22669545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Analysis of Skin Test Responses to Spherulin-Based Coccidioidin (Spherusol
    Ampel NM; Robey I; Nguyen CT
    Mycopathologia; 2019 Aug; 184(4):533-538. PubMed ID: 31309400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revision and return of a coccidioidal skin test reagent.
    Pappagianis D; Johnson SM
    Mycopathologia; 2012 Dec; 174(5-6):351-2. PubMed ID: 23065399
    [No Abstract]   [Full Text] [Related]  

  • 4. Coccidioides (spherulin) skin testing in patients with pulmonary coccidioidomycosis in an endemic region†.
    Mafi N; Murphy CB; Girardo ME; Blair JE
    Med Mycol; 2020 Jul; 58(5):626-631. PubMed ID: 31578560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivity to spherule-derived coccidioidin in the southeastern United States.
    Woodruff WW; Buckley CE; Gallis HA; Cohn JR; Wheat RW
    Infect Immun; 1984 Mar; 43(3):860-9. PubMed ID: 6199305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An archived lot of coccidioidin induces specific coccidioidal delayed-type hypersensitivity and correlates with in vitro assays of coccidioidal cellular immune response.
    Ampel NM; Hector RF; Lindan CP; Rutherford GW
    Mycopathologia; 2006 Feb; 161(2):67-72. PubMed ID: 16463089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Return of Delayed-Type Hypersensitivity Skin Testing for Coccidioidomycosis.
    Wack EE; Ampel NM; Sunenshine RH; Galgiani JN
    Clin Infect Dis; 2015 Sep; 61(5):787-91. PubMed ID: 25979308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical comparison of two Mexican coccidioidins.
    Castañón-Olivares LR; Laniado-Laborín R; Concepcion T; Muñoz-Hernández B; Aroch-Calderón A; Aranda-Uribe IS; Flores-Sánchez MA; del Rocío González-Martínez M; Hernández-Navarez A; Manjarrez-Zavala ME; Miranda-Mauricio S; Palma G; Pérez-Mejía A
    Mycopathologia; 2010 Jun; 169(6):427-30. PubMed ID: 20177972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of cellular immunity in human coccidioidomycosis.
    Ampel NM
    Mycopathologia; 2003; 156(4):247-62. PubMed ID: 14682448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring cellular immunity in coccidioidomycosis: the time is now.
    Ampel NM; Hector RF
    Mycopathologia; 2010 Jun; 169(6):425-6. PubMed ID: 20157783
    [No Abstract]   [Full Text] [Related]  

  • 11. The present status of vaccination against coccidioidomycosis in man.
    Pappagianis D; Levine HB
    Am J Epidemiol; 1975 Jul; 102(1):30-41. PubMed ID: 1155435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous sensitivity and in vitro responsiveness of lymphocytes in patients with disseminated coccidioidomycosis.
    Opelz G; Scheer MI
    J Infect Dis; 1975 Sep; 132(3):250-5. PubMed ID: 1159328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of coccidioidin and spherulin skin testing in the diagnosis of coccidioidomycosis.
    Gifford J; Catanzaro A
    Am Rev Respir Dis; 1981 Oct; 124(4):440-4. PubMed ID: 7294506
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical usefulness of lymphocyte transformation in patients with coccidioidomycosis.
    Barbee RA; Hicks MJ
    Chest; 1988 May; 93(5):1003-7. PubMed ID: 3359819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimates of C. immitis infection by skin test reactivity in an endemic community.
    Dodge RR; Lebowitz MD; Barbee R; Burrows B
    Am J Public Health; 1985 Aug; 75(8):863-5. PubMed ID: 4025646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of the coccidioidin skin test in patients with type diabetes mellitus in an endemic zone].
    Velasco-Rodríguez VM; Martínez-Ordaz VA; Padua y Gabriel A; Lazo-Sáenz JG; Cicero-Sabido R
    Rev Invest Clin; 2001; 53(3):223-7. PubMed ID: 11496709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin test antigens: an evaluation whose time has come.
    Chaparas SD
    Am Rev Respir Dis; 1978 Dec; 118(6):1109-10. PubMed ID: 742761
    [No Abstract]   [Full Text] [Related]  

  • 18. Dinitrochlorobenzene responsivity: difference between patients with severe pulmonary coccidioidomycosis and patients with disseminated coccidioidomycosis.
    Rea TH; Johnson R; Einstein H; Levan NE
    J Infect Dis; 1979 Mar; 139(3):353-6. PubMed ID: 448187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intradermal reactions with coccidioidins in different towns of San Luis Province].
    Bonardello NM; de Gagliardi CG
    Sabouraudia; 1979 Dec; 17(4):371-6. PubMed ID: 545714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coccidioidin skin reactivity in pulmonary coccidioidomycosis.
    Wiant JR; Smith JW
    Chest; 1973 Jan; 63(1):100-2. PubMed ID: 4684091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.